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Objective We propose a new method to measure health inequalities caused by conditions amenable to policy intervention and use 
this to identify health differences between sexes and age groups.
Methods The lowest observed mortality rates are used as a proxy of unavoidable mortality risks to develop a new measure of 
health outcome – realization of potential life years (RePLY). The RePLY distribution is used to measure avoidable health inequalities 
between sex and age groups respectively.
Findings Using RePLY we find that even those countries with very high life expectancy at birth can have substantial health 
inequalities across different age groups. Also, gender inequality is more pronounced among those aged < 30. Among countries with 
a life expectancy < 60 years, there is a much larger prevalence of gender inequality against females; countries with life expectancy 
> 60 years have comparable numbers of cases of inequality among females and males. Finally, high avoidable health inequality is 
associated with low average income, high income inequality and high population fractionalization.
Conclusion It is important to distinguish between unavoidable and avoidable mortality when measuring health outcomes and their 
distribution in society. The proposed new measure (RePLY) enables policy-makers to focus on age-sex groups with low realization 
of potential life years and thus high avoidable mortality risks.
Bulletin of the World Health Organization 2007;85:681–687.
Une traduction en français de ce résumé figure à la fin de l’article. Al final del artículo se facilita una traducción al español.
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Introduction
Although the past 50 years have seen 
substantial improvements in the average 
level of health as measured by mortality 
rates in many countries, health inequali-
ties have remained static or widened.1 
Against this background, in 2000 WHO 
declared the reduction of health inequal-
ities between and within countries to be 
a priority. It aims to use health inequal-
ity – in addition to the average level of 
health, average level and distribution of 
responsiveness and fairness in financial 
contributions – as a distinct parameter 
to assess the performance of national 
health systems.2 This paper contributes 
to health-inequality methodology by 
proposing a new measure for isolating 
health outcomes that are amenable to 
intervention.
Measurement of health inequality 
requires a health outcome or health 
status that is unidimensional and mea-
surable on a cardinal scale, much like 
income.3 Several variables satisfy these 
requirements (including height, body 
weight and child mortality) but we focus 
on age at death. Healthier persons are 
expected to live longer and age-at-death 
distribution is a frequently used measure 
of health inequality.4–7 However, not all 
fatal health outcomes have the same 
welfare implications, as demonstrated 
in the following example.
Person A died from a genetic dis-
order aged 40. If current technology 
cannot provide a cure for this disease, 
more health-related resources could not 
have extended A’s lifespan beyond 40. 
From a policy perspective, sufficient 
resources were expended to fully realize 
A’s potential life years. B died of malaria 
aged 60,  although with access to more 
health-related resources B would have 
been expected to live until, say, 80. From 
a policy perspective, B received resources 
that allowed the realization of only 75% 
of potential life years. Health inequality 
measured by age-at-death would have 
concluded that A should have received 
more, and B fewer, resources. That would 
have wasted resources and lowered the 
overall welfare of society.
Considering this limitation, we 
propose to define health equality as the 
state where everyone in the population 
can realize his/her own potential life 
years to the same degree. According to 
this definition, not everyone in a society 
that has achieved health equality will 
necessarily have an identical age at death. 
We propose a new measure to implement 
this concept – realization of potential 
life years (RePLY). RePLY is defined as 
the ratio of age at death to the potential 
length of life, and would replace age-at-
death as an indicator of health outcome. 
In the given example, A and B will have 
RePLYs equal to 1.0 and 0.75 respec-
tively. RePLY distribution can be used to 
measure health inequalities that have the 
potential to be reduced by reallocating 
resources within the population. Thus, 
the proposed measures are in line with 
WHO’s call for health systems to focus 
on the best attainable average level and 
on inequalities caused by conditions 
amenable to intervention.2
Unlike commonly used health in-
dexes (life expectancy; child mortality 
rate), RePLY can measure commensu-
rable differences between age and sex 
groups that are responsive to policy in-
tervention but not evidenced easily due 
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tional probability of dying for each 
age-sex group among all countries. It is 
considered practically as free from avoid-
able mortality risks for a given state of 
technology and the resources available to 
society at the time of measurement. The 
reference country’s mortality profile is 
the benchmark that defines unavoidable 
mortality risks. This approach, proposed 
by William Farr in the late nineteenth 
century, has been applied in several 
health-inequality studies.10–13
The conditional probability of dy-
ing for a person aged x in the reference 
country ( ~qx ) can be defined as:
K = number of countries.
qxk
 = conditional probability that a 
person in country k who survives to 
age x will die before reaching the next 
birthday.
The reference country mortality profile 
was constructed using the 191 countries 
in WHO’s life tables for 2000.14 Some 
have incomplete vital statistics, there-
fore any inequality measures derived 
for these countries should be used with 
caution. However, the derived RePLY-
based measures still reflect the avoidable 
health inequalities implied by the mod-
els used to construct the data. Moreover, 
results from sensitivity analyses show 
that the reference distribution of un-
avoidable mortality risks is very robust to 
this limitation. Details of the construc-
tion process, results and sensitivity tests 
can be found in two related studies.15,16
Fig. 1 shows the reference country 
mortality profile, constructed separately 
for females and males to allow for dif-
ferences in their natural mortality risks. 
If another country’s conditional prob-
ability of dying by age (e.g. Cambodia) 
is plotted on the same graph, its curves 
will lie above, or at best on, the reference 
curves. The reference curves constitute 
a “frontier” (when viewed from below) 
for mortality risks. The distance from 
the x-axis to the frontier is a measure 
of the unavoidable mortality risks; the 
distance from the probability curve to 
the frontier is a measure of avoidable 
mortality risks.
The number of unavoidable deaths 
in a given age-sex group is not directly 
observable but can be estimated by mul-
tiplying the group’s population with its 
conditional probability of dying from 
unavoidable causes. By definition, the 
latter is equal to the conditional prob-
ability of dying in the reference coun-
try for the same age-sex group. Once 
the number of unavoidable deaths is 
computed, the number of avoidable 
deaths can be obtained. Avoidable and 
unavoidable deaths are separated by the 
probability of death in each group rather 
than the actual causes of deaths. Thus, 
avoidable deaths in this paper include 
those that can be reduced by both medi-
cal and non-medical interventions (such 
as gun controls).
The incidence of global avoidable 
mortality will change as technology im-
proves.  It may go up or down, depend-
ing on whether the countries that define 
the frontier are getting farther ahead or 
whether the countries below it are catch-
ing up. Technological progress will shift 
the frontier distribution of unavoidable 
mortality risks down and away from 
other countries’ distributions, increas-
ing their avoidable mortality. It will also 
lower the cost of existing technologies, 
facilitating the development of health 
systems in poorer countries. Applied to 
Fig. 1, this effect could shift Cambodia’s 
probability curves downward, reducing 
its avoidable mortality. Thus RePLY 
can be used to analyse the dynamics of 
avoidable health inequalities when ap-
plied to panel data.
Computing for each type of 
death
Those who die from unavoidable causes 
have, by definition, fully realized the po-
tential lifespan that nature allows and 
have a RePLY equal to one. Conversely, 
to the natural differences in their mortal-
ity risks. Age-related health inequalities 
might not be particularly prominent on 
policy agendas, but implicit judgments 
on age-related inequality are made in 
almost all health policy decisions. For 
instance, often it is suggested that mea-
sures of the burden of disease should be 
age-weighted. Williams has proposed 
the “fair innings” argument for tak-
ing account of age-inequalities when 
evaluating the cost-effectiveness of dif-
ferent interventions.8,9 Gender-related 
inequality tends to be age-dependent. 
This prominent policy issue will be dis-
cussed further.
Methods
There are three steps for using RePLY 
to measure health inequalities: (1) sepa-
rating avoidable and unavoidable deaths 
for each age-sex group in a population; 
(2) computing the value of RePLY for 
each type of death for each age-sex group; 
(3) constructing health-inequality mea-
sures using the computed RePLY.
Avoidable and unavoidable 
deaths
Generally, mortality risks can be reduced 
by improving resource availability. 
However, some cannot be eliminated 
completely with current technology and 
resources. Risks such as those related to 
chance and genes are considered to be 
unavoidable (or natural) mortality risks. 
These are expected to vary with age, sex 
and time due to technological progress 
and environmental changes.
A reference country is a hypotheti-
cal country that has the lowest condi-
~qx  =  
min {qxk , k = 1,2,...,K }    x < X 
                           1                     x > X
Fig. 1. Conditional probability of dying by age and gender of the reference 
country and Cambodia
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Fig. 3. Average RePLY by age at death – females
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those who die from avoidable causes 
realize only a fraction: with as many 
health-related resources as their peers 
in the reference country, they would 
have had the same expected lifespan. 
Therefore, the RePLY for an avoidable 
death at age x is equal to x divided by 
(x + ~ex), where ~ex is the life expectancy 
for a person aged x in the reference 
country. Inequalities in RePLY indicate 
that the overall health outcome of the 
population can be improved by reallo-
cating resources between subgroups.
An alternative approach takes the 
maximum observed life expectancy 
among the 191 countries as the absolute 
standard of health status attainment. 
The shortfall between an observed life 
expectancy and this absolute standard 
is a measure of health outcome.8,17,18 
Although this method bears some simi-
larity to RePLY, it assumes that all 
deaths are avoidable, including those in 
the best-performing, standard-setting 
countries.
Mortality and morbidity are closely 
related and can interact in several dif-
ferent ways.19 Yet the state of mortality 
inequalities does not necessarily reflect 
that of morbidity. As more robust data 
become available on morbidity, it is 
desirable to extend RePLY to measure 
the avoidable loss of quality-adjusted 
life years (QALYs).
Constructing health-inequality 
measures
There is debate on whether health in-
equalities should be measured across in-
dividuals or population subgroups.20–24 
Ideally, we would like to measure both 
within- and between-group inequalities, 
and use other methods like regression 
or correlation to examine the factors af-
fecting total and partial inequalities.25 
However, the stratification of the WHO 
life tables limits our scope to age- and 
sex-related inequalities.
This paper focuses on intercountry 
inequalities and is more useful for inter-
national health monitoring and policy-
making. The method could be applied 
to construct a reference distribution 
across different regions within a coun-
try. This enables a focus on intracountry 
inequalities and thus is more helpful for 
determining health policy at local levels.
Findings
Scatter plots of both male and female 
RePLYs against age for selected coun-
tries are given (Fig. 2, Fig. 3). Japan’s 
RePLY for neonates is close to one, 
indicating a very small proportion of 
avoidable infant mortality. Nonetheless, 
Japanese male RePLY drops dramatically 
from age one, and does not return to 
the neonate-level until age 60. In the 
1–5 age group those who die have real-
ized, on average, less than 40% of their 
Fig. 2. Average RePLY by age at death – males
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potential life years. Japanese females 
also suffer a big drop in RePLY from age 
one, but recover to 0.9 level by the age 
of ten. The policy implication is that 
the Japanese health system may need to 
direct more attention, and possibly more 
resources, to children aged < 10.
We give a scatter plot of the ratio 
of male RePLY to female RePLY against 
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Fig. 4. Ratio of male to female average RePLY by age at death
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age (Fig. 4). A ratio greater (smaller) than 
one indicates gender inequality against 
females (males). China has the highest 
gender inequality for infants – an aston-
ishing 1.6 (i.e. RePLY is 60% higher for 
baby boys). This is likely to be related 
to the one-child policy and the social 
preference for boys.26 Conversely, in 
Japan and the Russian Federation, males 
are worse off for many subgroups aged 
< 50. This is probably related to high sui-
cide rates among young Japanese males 
and the impacts of alcohol abuse and 
violence on Russian males.27,28
A gender inequality prevalence 
index can be calculated using the male 
and female average RePLYs for each age 
group for each country:
The index is bounded between zero and 
one; a higher value indicates a greater 
prevalence of inequality against either 
females or males. We then compute the 
population-weighted and unweighted 
average of the index values across 191 
countries. As shown in Fig. 5, gender in-
equality is most prevalent for those aged 
< 30. This age group has substantially 
different weighted and unweighted index 
averages too, indicating that the degree 
of gender inequality varies substantially 
across countries.
National-level gender inequality is 
contrasted with life expectancy at birth 
Fig. 5. Average gender inequality prevalence index against age
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Union, including the Russian Federa-
tion (0.893) and Kazakhstan (0.918).
The prevalence of female inequality 
in developing countries may occur be-
cause the survival of males is considered 
to be more important in poor economic 
conditions.29,30 Also, when females (es-
pecially mothers) are in poor health, the 
health of their family members (particu-
larly children) may also suffer,31 leading 
to low life expectancy for the whole 
population.
Lastly, we investigate how the 
health-inequality measures based on 
RePLY relate to inequality measures 
based on other parameters. Table 1 
(available at: http://www.who.int/ 
bulletin/volumes/85/9/06-037382/
en/index.html) shows the correlation 
coefficients between the RePLY Gini 
coefficient and the gender inequality 
prevalence index; and between GDP 
per capita, income Gini coefficient and 
three population fractionalization in-
dexes.32 All indexes are measured at the 
national level, and a larger fractionaliza-
tion index value means the population 
is more heterogeneous along that di-
mension. As expected, avoidable health 
inequality is correlated negatively to 
average income level but positively to 
income inequality. Avoidable health 
inequality correlates positively to three 
(Fig. 6). Most countries with relatively 
low life expectancy at birth also have 
higher female inequality. Countries 
with relatively high life expectancy at 
birth show equally prevalent inequalities 
against males and females. The high-
est female inequalities are found mostly 
in low-income south Asian or African 
countries, such as Nepal (1.087) and 
Botswana (1.085); the highest male 
inequalities are found mostly among 
independent states of the former Soviet 
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Fig. 6. Ratio of male to female average RePLY against life expectancy at birth 
across countries
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measures of population fractionaliza-
tion, although the correlation with the 
religion fractionalization index is much 
smaller. Ethnicity and language are as-
sociated with health status because they 
are considered to reflect the effects of 
culture, class, life-course changes, dis-
crimination, geographical self-clustering 
and isolation from the mainstream.33
Gender-related health inequality, 
as measured by the prevalence index, 
is found to have a much smaller cor-
relation with the five socioeconomic 
indicators, yet the signs match those of 
the RePLY Gini coefficient. A possible 
explanation is that most gender in-
equality takes place within, rather than 
between, different income or ethnolin-
guistic groups.
Conclusion
Using the mortality rate frontier among 
a large number of countries as a bench-
mark of unavoidable mortality risks, we 
construct a measure of individual health 
outcome – RePLY. This can illustrate 
the health inequalities caused by condi-
tions that are amenable to intervention, 
thereby helping policy-makers to iden-
tify the most cost-effective interventions 
to reduce inequalities and improve 
health. The proposed measure echoes the 
notion of effective coverage suggested 
recently by Shengelia and colleagues.34
RePLY’s usefulness is demonstrated 
by examining age- and gender-related 
health inequalities among 191 coun-
tries. RePLY-based measures are more 
informative than conventional measures 
(such as life expectancy) as they expose 
inequalities that are concealed by differ-
ences in natural mortality risks between 
age and gender groups. RePLY can be 
applied readily to measure inequalities 
along other socioeconomic dimen-
sions, such as ethnicity or class, and 
extended to incorporate morbidity as 
well as mortality. Since the inequalities 
measured can be alleviated by reallocat-
ing resources between groups within a 
population, RePLY can reflect not only 
health inequality but also social disad-
vantage.35  O
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Résumé
Mesure des inégalités sanitaires entre les sexes et les tranches d’âges en termes d’années de vie 
potentielles vécues (RePLY)
Objectif Nous proposons une nouvelle méthode pour mesurer 
les inégalités en termes de santé pouvant être réduites par des 
interventions et nous l’utilisons pour identifier les différences en 
termes de santé entre les sexes et les tranches d’âges.
Méthodes Les taux de mortalité les plus bas observés ont été 
utilisés comme approximation des risques mortels inévitables afin 
de mettre au point un nouveau paramètre de mesure des résultats 
dans le domaine sanitaire : les années de vie potentielles vécues 
(RePLY). La distribution des RePLY est utilisée pour mesurer les 
inégalités en matière de santé évitables entre les sexes et les 
classes d’âges.
Résultats A l’aide de cette mesure, nous constatons que les pays 
bénéficiant d’une très longue espérance de vie à la naissance 
peuvent présenter des inégalités substantielles en matière de 
santé entre les classes d’âges. De même, les inégalités liées au sexe 
sont plus prononcées chez les moins de 30 ans. Dans les pays où 
l’espérance de vie est inférieure à 60 ans, on relève une prévalence 
bien plus marquée des inégalités liées au sexe en défaveur des 
femmes ; dans les pays où l’espérance de vie dépasse 60 ans, 
les nombres de cas d’inégalités entre hommes et femmes sont 
comparables. Enfin, d’importantes inégalités évitables en matière 
de santé sont associées à de faibles revenus moyens, à de fortes 
inégalités en matière de revenus et à un fort fractionnement de 
la population.
Conclusion Il importe de faire la distinction entre mortalité évitable 
et inévitable lorsqu’on mesure des paramètres sanitaires et leur 
distribution dans la société. La nouvelle mesure proposée (RePLY) 
permet aux décideurs de cibler leur action sur les groupes, constitués 
en fonction de l’âge ou du sexe, qui ne réalisent qu’une faible partie 
de leur potentiel de vie et ainsi sur les risques mortels évitables.
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صخلم
ةنكملما رمعلا تاونس سايقم مادختساب ةيرمعلا تائفلا ينبو ينسنجلا ينب توافتلاو روجلا رهاظم سايق
 توافتلاو روجلا رهاظم سايقل ةديدج ةقيرط ةقرولا هذه في حرطن :ضرغلا
 للاخ  نم  اهيلع  بُّلغتلا  نكيم  عا�ضوأ  نع  ةمجانلا  ،يحصلا  لاجلما  في
 ةيحصلا  قورفلا  ديدحت في ةقيرطلا  هذه نم ةدافتسلاا ةيفيكو ،تاسايسلا
.ةيرمعلا تائفلا ينبو ينسنجلا ينب
 ًلايدب  ًاشرؤم اهفصوب ،ةظحلالما تايفولا  تلادعم نىدأ تمدخُتسا  :ةقيرطلا
 ةيحصلا ةليصحلل ديدج سايقم عضول ،اهبنجت نكيم لا يتلا ةافولا رطاخلم
 ةنكملما  رمعلا  تاونس  عُّزو�ت  مدخُتساو  .ةنكملما  رمعلا  تاونس  وهو  –
 تائفلا ينبو ينسنجلا ينب يحصلا لاجلما في توافتلاو روجلا رهاظم سايقل
.ةيرمعلا
 هنأ لىإ ةنكملما رمعلا تاونس سايقم قيبطت للاخ نم انلصوت :تادوجولما
 نياعت  دق  ،ةدلاولا  دنع  عافترلاا  غلاب  ةايح لومأبم عَّتمتت  يتلا  نادلبلا  ىتح
 ظحول ماك .ةيرمعلا تائفلا فلتخم في توافتلاو روجلل ةحضاو رهاظم نم
 .ًاماع 30 رمع نم لقأ مه نم ينب ًاحوضو ثركأ توافتلاو روجلا رهاظم نأ
 روجلا رهاظم شرتنت ،ًاماع 60 نع اهيف ةايحلا لومأم لقي يتلا نادلبلا فيو
 ةايحلا لومأم ديزي يتلا نادلبلا في امأ ؛ثانلإا دض اضيرع اراشتنا توافتلاو
 ثانلإا ينب توافتلاو روجلا تلااح ددع براقت ظحلاُيف ،ًاماع 60 لىع اهيف
 دح لىإ اهبُّنجت نكيم يتلا ،توافتلاو روجلا رهاظم نأ كلذك ظحولو .روكذلاو
 لخدلا تايوتسم في توافتلا ةدايزو لخدلا ىوتسم ضافخناب طبترت ،ديعب
.ناكسلا تُّتفت ة َّدشو
 يتلا كلت ينبو اهبنجت نكيم يتلا تايفولا ينب قيرفتلا مهلما نم :جاتنتسلاا
 .عمتجلما  في  اهعُّزوتو  ةيحصلا  لئاصحلا  سايق  دنع  كلذو  ،اهبُّنجت  نكيم  لا
 تاسايسلا يمسارل )ةنكملما رمعلا تاونس( حَر�َتقُم�لا ديدجلا سايقلما حيتيو
 ،ةنكملما رمعلا تاونس سايقم في ةضفخنلما سنجلاو رمعلا تائف لىع زيكر�تلا
.اهبُّنجت نكيم يتلا ةافولا رطاخلم ةضرع دشأ نوكت مث نمو
Resumen
Medición de las desigualdades sanitarias entre sexos y grupos de edad con la realización de los años de 
vida potenciales (RAVP)
Objetivo Proponemos un nuevo método para medir las 
desigualdades sanitarias causadas por trastornos que puedan 
modificarse con intervenciones de políticas y lo hemos utilizado 
para identificar diferencias sanitarias entre los sexos y entre 
diferentes grupos de edad.
Métodos Utilizando las menores tasas de mortalidad observadas 
como indicador indirecto del riesgo de mortalidad inevitable, 
hemos creado una nueva medida de los resultados sanitarios, 
denominada realización de los años de vida potenciales (RAVP), 
cuya distribución utilizamos para medir las desigualdades 
sanitarias evitables entre los sexos y entre diferentes grupos de 
edad.
Resultados Utilizando la RAVP, verificamos que incluso los países 
con una esperanza de vida muy elevada al nacer pueden presentar 
desigualdades sanitarias considerables entre diferentes grupos 
de edad. Las desigualdades entre sexos son más marcadas entre 
los menores de 30 años. En los países con una esperanza de vida 
< 60 años hay una prevalencia mucho mayor de desigualdades 
entre sexos desfavorables a las mujeres; los países con esperanza 
de vida > 60 años tienen cifras similares de desigualdades 
desfavorables a los hombres y a las mujeres. Las grandes 
desigualdades sanitarias evitables se asociaron a bajos ingresos 
medios, grandes desigualdades de ingresos y gran fraccionamiento 
de la población.
Conclusión A la hora de medir los resultados sanitarios y 
su distribución en la sociedad es importante distinguir entre 
mortalidad evitable e inevitable. La nueva medida propuesta 
permite a los planificadores de políticas centrarse en los sexos y 
los grupos de edad con baja RAVP y, por consiguiente, alto riesgo 
de mortalidad evitable.
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Table 1. Correlation between RePLY-based inequality measures and socioeconomic 
factors
RePLY Gini  
coefficient
Gender inequity  
prevalence index
GDP per capita –0.65 –0.34
Income Gini coefficient 0.55 0.17
Ethnicity fractionalization 0.57 0.22
Language fractionalization 0.54 0.27
Religion fractionalization 0.14 0.11
Sources: Income Gini coefficient data are drawn from the UNU/WIDER World Income Inequality 
Database, version 2.0 beta (available at: www.wider.unu.edu/wiid/WIID2beta.pdf) based on disposable 
income wherever possible, otherwise net income. Only countries that WIDER classifies as having reliable 
data are selected. Income inequality indices for 2000 are used when available; otherwise indices for the 
next closest year are used, allowing a maximum difference of 5 years. Only 77 countries are included 
in this calculation due to non-availability of income inequality data – 29 of the 77 are OECD countries. 
GDP per capita data are drawn from the World Development Indicators 2005 (Washington: World Bank; 
2005). The figures are expressed in terms of PPP (constant 2000 international dollars); 159 countries are 
included. Ethnicity, language and religion fractionalization indexes are drawn from a study by Alesina et 
al. (Alesina A, Devleeschauwer A, Easterly W, Kurlat S, Wacziarg R. Fractionalization. Journal of Economic 
Growth 2003: 8:155-94). Ethnicity data are from various years, covering 185 countries. Language and 
religion data are from 2001, covering 178 and 187 countries respectively.
